Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …

Pre-eclampsia is a complication of pregnancy that is associated with substantial maternal
and fetal morbidity and mortality. The disease presents with new-onset hypertension and …

Preeclampsia (PE) is an often fatal pathology characterized by hypertension and proteinuria
at the 20th week of gestation that affects 5–10% of the pregnancies. The problem is …

Preeclampsia is a pregnancy-specific disorder that affects 2–8% of all pregnancies and
remains a leading cause of maternal and perinatal morbidity and mortality worldwide …

Effective screening for the development of early onset preeclampsia (PE) can be provided in
the first‐trimester of pregnancy. Screening by a combination of maternal risk factors, uterine …

Objective To determine the risk of pre-eclampsia associated with factors that may be present
at antenatal booking. Design Systematic review of controlled studies published 1966-2002 …

OBJECTIVE: We sought to validate several clinical risk factors previously described for
preeclampsia in a large contemporary multicenter prospective cohort. METHODS: We …

Background. Maternal obesity, both in itself and as part of the insulin resistance syndrome, is
an important risk factor for the development of preeclampsia. Accurately quantifying the …

Objectives To develop a predictive model for pre-eclampsia based on clinical risk factors for
nulliparous women and to identify a subgroup at increased risk, in whom specialist referral …

Background Maternal placental syndromes, including the hypertensive disorders of
pregnancy and abruption or infarction of the placenta, probably originate from diseased …